Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 2 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

1
Player Avatar SnowBawl (< 20) Submitted: 10/23/2011 5:11:04 AM : Outperform Start Price: $34.74 QCOR Score: -12.28

#1 best small public company.

Featured Broker Partners


Advertisement